Clinical Trials Logo

Clinical Trial Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults. It is a major cause of ischemic stroke and heart failure. Intravascular cardiac ablation of the left atrium by catheter delivery is an efficient treatment to restore sinus rhythm. AF ablation is a class IIa treatment for patients with symptomatic persistent AF refractory or intolerant to antiarrhythmic medication. There are still many debates considering the ablation strategy. The pulmonary veins remain the cornerstone of AF ablation therapy, even in persistent AF. There is a large electrical remodeling occurring in the left atrium between paroxysmal AF, early persistent AF and long-standing persistent AF. However, no multicentric and randomized study has demonstrated so far the interest of targeting other left atrial substrate, such as rotors or focal sources.

Our study aims to describe with a noninvasive mapping system the arrhythmogenic substrate of persistent AF > 6 months pre- and post-cardioversion, and after pulmonary vein isolation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04229160
Study type Interventional
Source University Hospital, Rouen
Contact Frédéric ANSELME, Pr
Phone +3323288
Email frederic.anselme@chu-rouen.fr
Status Recruiting
Phase N/A
Start date June 9, 2020
Completion date June 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04544397 - Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
Completed NCT04473963 - FLOW-AF: A Study to Evaluate the Ablacon Electrographic FLOW EGF Technology N/A
Recruiting NCT04715425 - Thoracoscopic Surgical Versus Catheter Ablation Approaches for Primary Treatment of Persistent Atrial Fibrillation N/A
Completed NCT04045067 - Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation
Enrolling by invitation NCT04148625 - Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation
Active, not recruiting NCT05481359 - AF-FLOW Registry: This Study is to Evaluate Ablamap Software in Patients Undergoing Ablation for Atrial Fibrillation.
Completed NCT06260670 - FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation N/A
Recruiting NCT05883631 - RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. N/A
Recruiting NCT04942834 - Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation N/A
Recruiting NCT04606693 - Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates N/A
Enrolling by invitation NCT04508491 - Cognitive Function in Patients With Persisted Atrial Fibrillation N/A
Active, not recruiting NCT05507749 - Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring N/A
Not yet recruiting NCT06098989 - A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study) N/A
Recruiting NCT05575557 - Pulmonary Artery Pressure and Right Heart Evaluation for Patients Requiring Physiological Pacing Treatment N/A
Recruiting NCT05411614 - Hybrid AbLaTion of Atrial Fibrillation N/A
Recruiting NCT04342312 - Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
Recruiting NCT04542785 - Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clinical Trial N/A
Recruiting NCT04237389 - Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation N/A
Terminated NCT04206917 - MultiPulse Therapy (MPT) for AF N/A
Not yet recruiting NCT05883722 - Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation N/A